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The search for eternal youth is age old. In a recent Nature paper, Boon et al. (2013) describe DNA damage
mechanisms and cardiac senescence provoked by miR-34a and its target, PNUTS. Interrupting this pathway
may prevent age- and stress-induced cardiac degeneration.‘‘Middle age ends and senescence
begins, the day your descendants
outnumber your friends.’’
(Ogden Nash)
‘‘It’s not the years, honey, it’s the
mileage.’’
(Indiana Jones,
Raiders of the Lost Ark, 1981)
Ifwe are fortunate,wewill all get old. But
there are striking interindividual differ-
ences in the aging phenotype, and the
consequences of aging on different organ
systems within a given individual are
inconsistent. Senescence is therefore var-
iable and potentially modifiable. Caloric
restriction extends lifespan and dimin-
ishes age-related functional decline via
activation of sirtuin family (SIRT) NAD-
dependent deacetylases (Lin et al.,
2000). The possibility that master regula-
tory factors such as SIRTs determine
aging phenotypes is attractive because it
suggests gene-based interventions to
prevent or delay senescence. The ability
of microRNAs (miRNAs) to directly modu-
late messenger RNA (mRNA) stability and
protein translation, and to indirectly regu-
late gene transcription and posttransla-
tional protein modification within a com-
mon biological pathway (Hu et al., 2012),
makes them attractive candidate orches-
trators of programmed senescence
or anti-aging/reparative processes. Re-
cently, Boon et al. (2013) identified miR-
34a as a central factor provoking cell dete-
rioration in the aging or infarcted heart.
miR-34a is a ubiquitously expressed
microRNA transcriptionally regulated by
a tumor suppressor gene, p53 (Chang
et al., 2007), that encodes a transcription
factor tasked with coordinating cellular
responses to DNA damage (Figure 1). To
fully appreciate the implications of miR-34a on cardiac senescence, it is helpful
to understand the interactions between
DNA damage, induction of p53, and regu-
lation of miR-34a. Modest DNA damage
induces low levels of p53 that activate
endogenous DNA repair pathways and
promote cell rejuvenation, whereas se-
vere DNA damage that is beyond repair
induces high levels of p53 that eliminate
the cell via apoptosis (Figure 1). Cell
senescence is induced by intermediate
levels of DNA damage and p53 activation
that induce cell-cycle arrest at the G2-M
DNA damage checkpoint, permitting
extensive DNA repair. Permanent cell-
cycle arrest at this DNA damage check-
point defines cellular senescence (Col-
lado et al., 2007). The critical effectors
linking DNA damage, p53, and miR-34a
signaling (Figure 1) were discovered in
several cancers (Chang et al., 2007), and
important regulatory roles were described
for the anti-aging protein sirtuin 1 (SIRT1)
(Figure 1) and epigenetic miR-34a sup-
pression via methylation of its promoter
(Figure 1). Whereas cancer is associated
with decreased miR-34a, its levels in-
crease with senescence in normal hearts
and spleens, contributing to age-related
decreases in SIRT1 levels (Ito et al., 2010).
In a recent paper published in Nature,
Boon et al. (2013) identified a novel
pathway by which age-related increases
in miR-34a contribute to cardiac senes-
cence via a mechanism that seems inde-
pendent of SIRT1. Parallels are described
between miR-34a mediation of functional
cardiac deterioration with age and after
myocardial infarction (MI). Thus, cardiac
miR-34a levels approximately doubled
with age in mouse and human hearts and
increased in MI border zones. Therapeuti-
cally, miR-34a gene ablation or miR-34a
suppression by locked nucleic acid-basedCell MetabolisantimiRs improved left ventricular ejection
performance, diminished cardiomyocyte
apoptosis, and improved ventricular re-
modeling in age-induced cardiac senes-
cence (18-month-old mice), a genetic
model of accelerated aging (Ku80
knockout mice) and post-MI. The central
factor in this schema is the phosphatase-
1 nuclear targeting subunit (PNUTS),
identified as a novel miR-34a target using
bioinformatics analyses and validated
using luciferase reporter assays. Age-
or MI-related increases in miR-34a
decreased PNUTS levels. Consequently,
forced PNUTS expression reduced age-
and miR-34a-related markers of DNA
damage and protected cardiomyocytes
from apoptosis by preventing telomere
shortening (a marker of senescence) and
promoting other aspects of the DNA
damage response. These findings reveal
a novel, SIRT1-independent arm of miR-
34a signaling (Figure 1).
PNUTS is a catalytically inactive
nuclear-localized protein whose titular
function is to complex with protein phos-
phatase-1 (PP1), targeting it to nuclear
DNA during mitosis telophase and pro-
moting PP1-mediated chromosome de-
condensation necessary for interphase.
Because PP1 reverses cyclin-dependent
kinase-mediated phosphorylation of the
retinoblastoma protein (Rb), dissociation
of PNUTS from PP1 provoked by cellular
stress can regulate cell proliferation and
apoptosis (De Leon et al., 2008) (Figure 1).
PNUTS also has multiple PP1-indepen-
dent functions in cell growth and DNA
damage response pathways: PNUTS
positively regulates cytoprotective PI3K/
Akt signaling through nuclear sequestra-
tion of another phosphatase, PTEN,which
converts Akt-activating PIP3 to inactive
PIP2 (Kavela et al., 2013) (Figure 1).m 17, May 7, 2013 ª2013 Elsevier Inc. 629
Figure 1. Simplified Schematic of miR-34a/PNUTS and Related
Signaling Pathways that Determine Cell Survival, Senescence, and
Programmed Death
DNA damage activates tumor suppressor p53, initiating p53 activity-depen-
dent DNA repair (blue), senescence/cell-cycle arrest (yellow), and apoptosis
signaling (red) pathways. miR-34a expression is increased by p53 and feeds
back to p53 via its mRNA target, the anti-aging/cell survival factor SIRT1
(green). As shown in Boon et al. (2013), miR-34a also targets PNUTS, which
is a multifunctional modulator of cell growth (green), cell death, and DNA
damage repair pathways. Critical effectors of the various pathways are indi-
cated. mCpG indicates DNA hypermethylation. RISC: RNA-induced silencing
complex.
Cell Metabolism
PreviewsPNUTS interacts with telo-
mere repeat factor 2 (TRF2)
(Kim et al., 2009), which pro-
tects chromosome ends by
enforcing a T-loop structure.
DNA damage promotes
PNUTS translocation to, and
repair of, double-stranded
DNA breaks during the G2-M
checkpoint (Landsverk et al.,
2010) (Figure 1). As a con-
sequence of these parallel
effects on multiple targets,
modest PNUTS suppres-
sion with RNA interference
(RNAi), and perhaps by
increased miR-34a, prolongs
the normal DNA damage
checkpoint and delays DNA
repair in injured cells (i.e.,
promotes cell senescence)
(Landsverk et al., 2010), thus
provoking p53-independent
apoptosis (De Leon et al.,
2008). Boon et al. (2013)
have extended these findings
and provided insight into how
epitranscriptional program-
ming of aging and injured
hearts directs genetically
programmed senescence.The advantages of limiting DNA dam-
age that accumulates with aging or is
induced by injury are obvious. Mended
cells can re-enter the cell cycle, while cells
that are beyond repair are apoptotically
culled or placed in permanent cell-cycle
arrest to contain the damaged genomic
contagion. This explains the tumor-sup-
pressive function of miR-34a and p53.
The unresolved question is how protec-
tive DNA repair and resulting permanent
cell-cycle arrest (i.e., cellular senescence
[Collado et al., 2007]) impacts the heart,
since cardiac myocytes are essentially
amitotic. An intriguing possibility is that630 Cell Metabolism 17, May 7, 2013 ª2013the miR-34a/PNUTS axis is active not
only in aging and injured cardiac myo-
cytes, but also in the resident cardiomyo-
cyte progenitor cells that are essential for
myocardial maintenance and renewal.
Cardiac stem cells decline with age, and
miR-34a/PNUTS-mediated progenitor
cell depletion and/or proliferative arrest
would further impair the intrinsic regener-
ative capacity of the heart by destroying
its reservoir of cardiomyocyte-producing
cells, leading to the net loss of myocar-
dium and functional cardiac insufficiency
that is seen with aging and late post-MI.
Whether and how stem cell depletion byElsevier Inc.miR-34a contributes to car-
diac senescence requires
further evaluation.
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